One month ago, NIA announced BetterLife Pharma (CSE: BETR) as its #1 psychedelic pick for 2021 at $1.25 per share. BETR rose to a high so far of $2.27 per share for a gain of 81.6%!
This morning, NIA announced Entheon Biomedical (CSE: ENBI) at $1.02 per share as its #2 favorite psychedelic pick for 2021 and #1 favorite DMT stock suggestion. According to Google Trends, global searches for "what is DMT" have hit a new all-time high this month! More people are searching for information about DMT right now than any other psychedelic drug! ENBI is the only publicly traded DMT pure play!
NIA's #3 favorite psychedelic pick for 2021 is Delic Holdings (CSE: DELC) currently $0.62 per share. Today, DELC listed on the U.S. OTC for the very first time under the symbol DELCF.
DELC is one of the lowest market cap psychedelic plays with a small float. DELC owns very valuable online media assets related to psychedelics and NIA's President intends to become an advisor to the company!
Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is not a solicitation or recommendation to buy, sell, or hold securities. NIA has received compensation from BETR of USD$50,000 cash and expects to receive an additional USD$50,000 worth of restricted BETR shares for a six-month marketing contract. NIA previously received compensation from BETR of USD$50,000 cash for a six-month marketing contract which has since expired. NIA has received compensation from ENBI of USD$30,000 cash for a three-month marketing contract. NIA has received compensation from DELC of USD$25,000 cash and expects to receive 150,000 shares of restricted DELC stock for a six-month marketing contract. This message is meant for informational and educational purposes only and does not provide investment advice.